Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Chest discomfort, Feeling abnormal, Flushing, Throat tightness
Clinical narrative: she started having facial swelling and hives; anaphylaxis; she can't work all this time at this point and it's been a mess since getting the Pfizer Covid-19 vaccine; She is still hard of breath; She has a heavy chest; she started having facial swelling and hives; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 48-years-old female patient received BNT162b2 (BNT162B2), on 07Jul2022 as dose 1, single (Lot number: FM7553) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Allergies: sulfate drugs" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Nsaids, reaction(s): "drug allergy"; Ibuprofen, reaction(s): "drug allergy".  The following information was reported: CHEST PAIN (non-serious) with onset 07Jul2022, outcome "unknown", described as "She has a heavy chest"; DYSPNOEA (non-serious) with onset 07Jul2022, outcome "unknown", described as "She is still hard of breath"; ANAPHYLACTIC REACTION (hospitalization, medically significant) with onset 07Jul2022, outcome "not recovered", described as "anaphylaxis"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 07Jul2022, outcome "unknown", described as "she can't work all this time at this point and it's been a mess since getting the Pfizer Covid-19 vaccine"; SWELLING FACE (hospitalization), URTICARIA (non-serious) all with onset 07Jul2022, outcome "unknown" and all described as "she started having facial swelling and hives". The patient was hospitalized for anaphylactic reaction (start date: 07Jul2022, discharge date: 08Jul2022, hospitalization duration: 1 day(s)). The event "anaphylaxis" required emergency room visit. Therapeutic measures were taken as a result of anaphylactic reaction, swelling face, dyspnoea, chest pain, urticaria.  Clinical course: Caller was calling to report anaphylactic shock with Pfizer COVID-19 vaccine. She was also asking if there was any financial assistance for medical bills. She had to go the Emergency room 3-4 times. She was an HCP. She got her first COVID-19 vaccine on 07Jul2022 and had anaphylactic reaction within minutes of the injection. She was still hard of breath and everything. She had a heavy chest. She could not talk and breath at the same time. She had an anaphylactic reaction 3 times after the vaccine. She was admitted the second time because she started having facial swelling and hives, the stuff was still in her system, and this was within an hour period. All on 07Jul2022, about 5 hours after the injection, she was admitted/ hospitalized and observed for 24 hours. When she got home, she was already going into anaphylactic shock again, that was at almost the 48-hour mark that she went into anaphylactic shock again. About treatment it was reported that, for the first time she was injected epi pen to open airways, then went to the hospital to get Pepcid for a histamine blocker and prednisone Benadryl IV. For the second time, she was injected epi in arm and everything else the same Pepcid and prednisone. For the third time, she was injected with an epi pen and was transported by ambulance to the hospital where they did Pepcid and Prednisone (liquid IV). She did not go to her doctor but went to urgent care last night because of her heavy chest. They gave her a breathing treatment and an inhaler to use. No additional vaccines were administered on same date of the Pfizer suspect had no prior Vaccinations (within 4 weeks) of vaccination.